Development of novel medicines using high resolution native mass spectrometry of intact protein assemblies

OMass is an Oxford University spin-out that is harnessing high-resolution native mass spectrometry and other biophysical technologies to drive drug discovery in high definition for immunology and genetic disease.

Date: 7 September 2021, 12:00
Venue: Zoom
Speaker: Dr Katharina Duerr (OMass Therapeutics)
Organising department: Divisional Office (MSD)
Organisers: Sheena Lee (MSD Business Partnerships Office), Medical Sciences Division Business Partnerships Office (University of Oxford)
Organiser contact email address: sheena.lee@medsci.ox.ac.uk
Host: Sheena Lee (MSD Business Partnerships Office)
Part of: Industry Insight Seminar Series
Booking required?: Required
Booking url: https://www.eventbrite.co.uk/e/industry-insights-seminar-series-tickets-131313804123
Cost: Free
Audience: Members of the University of Oxford and the Biotech/Pharma industry
This talk features in the following public collections:
- Talks of Interest to Medical Sciences
- Innovation & Translation related talks
Editor: Sheena Lee